カテゴリー： 世界, 医療/バイオ, Market Monitor Global

世界の運動促進薬市場予測2023-2029：メトクロプラミド、ドンペリドン、シサプリド、その他

【英語タイトル】Prokinetic Drug Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが出版した調査資料（MMG23LY8609）・商品コード：MMG23LY8609
・発行会社（調査会社）：Market Monitor Global
・発行日：2023年7月
・ページ数：70
・レポート言語：英語
・レポート形式：PDF
・納品方法：Eメール（受注後2-3営業日）
・調査対象地域：グローバル、北米、アメリカ、ヨーロッパ、アジア、日本、中国、東南アジア、インド、南米、中東・アフリカなど
・産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明
※お支払金額：換算金額（日本円）＋消費税
※納期：即日〜2営業日（3日以上かかる場合は別途表記又はご連絡）
※お支払方法：納品日＋5日以内に請求書を発行・送付（請求書発行日より2ヶ月以内に銀行振込、振込先：三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能）
❖ レポートの概要 ❖

当調査レポートは次の情報を含め、世界の運動促進薬市場規模と予測を収録しています。・世界の運動促進薬市場：売上、2018年-2023年、2024年-2029年
・世界の運動促進薬市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界の運動促進薬市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。米国市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「メトクロプラミド」セグメントは今後6年間、000%のCAGRで2029年までに000Mドルに成長すると予測されています。

運動促進薬のグローバル主要企業は、Sumitomo、 Johnson & Johnson、 Sanofi、 Kyowa Kirin Pharmaceuticals、 Pfizer、 Teva、 Cadila Pharmaceuticals、 Hanmi Pharmなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

MARKET MONITOR GLOBAL（MMG）は、運動促進薬のメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別市場分析】

世界の運動促進薬市場：タイプ別、2018年-2023年、2024年-2029年
世界の運動促進薬市場：タイプ別市場シェア、2022年
・メトクロプラミド、ドンペリドン、シサプリド、その他

世界の運動促進薬市場：用途別、2018年-2023年、2024年-2029年
世界の運動促進薬市場：用途別市場シェア、2022年
・胃不全麻痺、便秘、逆流性食道炎、機能性ディスペプシア

世界の運動促進薬市場：地域・国別、2018年-2023年、2024年-2029年
世界の運動促進薬市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競合分析】

また、当レポートは主要な市場参加者の分析を提供します。
・主要企業における運動促進薬のグローバル売上、2018年-2023年
・主要企業における運動促進薬のグローバル売上シェア、2022年
・主要企業における運動促進薬のグローバル販売量、2018年-2023年
・主要企業における運動促進薬のグローバル販売量シェア、2022年

さらに、当レポートは主要企業のプロファイルを提示します。
Sumitomo、 Johnson & Johnson、 Sanofi、 Kyowa Kirin Pharmaceuticals、 Pfizer、 Teva、 Cadila Pharmaceuticals、 Hanmi Pharm

*************************************************************

・調査・分析レポートの概要
運動促進薬市場の定義
市場セグメント
世界の運動促進薬市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界の運動促進薬市場規模
世界の運動促進薬市場規模：2022年 VS 2029年
世界の運動促進薬市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでの運動促進薬の売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業の運動促進薬製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：メトクロプラミド、ドンペリドン、シサプリド、その他
運動促進薬のタイプ別グローバル売上・予測

・用途別市場分析
用途区分：胃不全麻痺、便秘、逆流性食道炎、機能性ディスペプシア
運動促進薬の用途別グローバル売上・予測

・地域別市場分析
地域別運動促進薬市場規模 2022年と2029年
地域別運動促進薬売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業のプロファイル（企業概要、事業概要、主要製品、売上、ニュースなど）
Sumitomo、 Johnson & Johnson、 Sanofi、 Kyowa Kirin Pharmaceuticals、 Pfizer、 Teva、 Cadila Pharmaceuticals、 Hanmi Pharm
...

A prokinetic agent (also gastroprokinetic agent, gastrokinetic agent or propulsive) is a type of drug which enhances gastrointestinal motility by increasing the frequency or strength of contractions, but without disrupting their rhythm. They are used to treat certain gastrointestinal symptoms, including abdominal discomfort, bloating, constipation, heart burn, nausea, and vomiting; and certain gastrointestinal disorders, including irritable bowel syndrome, gastritis, gastroparesis, and functional dyspepsia.
This report aims to provide a comprehensive presentation of the global market for Prokinetic Drug, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Prokinetic Drug. This report contains market size and forecasts of Prokinetic Drug in global, including the following market information:
Global Prokinetic Drug Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Prokinetic Drug Market Sales, 2018-2023, 2024-2029, (K Units)
Global top five Prokinetic Drug companies in 2022 (%)
The global Prokinetic Drug market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Metoclopramide Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Prokinetic Drug include Sumitomo, Johnson & Johnson, Sanofi, Kyowa Kirin Pharmaceuticals, Pfizer, Teva, Cadila Pharmaceuticals and Hanmi Pharm, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Prokinetic Drug manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Prokinetic Drug Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, by Type, 2022 (%)
Metoclopramide
Domperidone
Cisapride
Others
Global Prokinetic Drug Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, by Application, 2022 (%)
Gastroparesis
Constipation
Reflux Esophagitis
Functional Dyspepsia
Global Prokinetic Drug Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Units)
Global Prokinetic Drug Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Prokinetic Drug revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Prokinetic Drug revenues share in global market, 2022 (%)
Key companies Prokinetic Drug sales in global market, 2018-2023 (Estimated), (K Units)
Key companies Prokinetic Drug sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Sumitomo
Johnson & Johnson
Sanofi
Kyowa Kirin Pharmaceuticals
Pfizer
Teva
Cadila Pharmaceuticals
Hanmi Pharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Prokinetic Drug, market overview.
Chapter 2: Global Prokinetic Drug market size in revenue and volume.
Chapter 3: Detailed analysis of Prokinetic Drug manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Prokinetic Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Prokinetic Drug capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Prokinetic Drug Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Prokinetic Drug Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Prokinetic Drug Overall Market Size
2.1 Global Prokinetic Drug Market Size: 2022 VS 2029
2.2 Global Prokinetic Drug Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Prokinetic Drug Sales: 2018-2029
3 Company Landscape
3.1 Top Prokinetic Drug Players in Global Market
3.2 Top Global Prokinetic Drug Companies Ranked by Revenue
3.3 Global Prokinetic Drug Revenue by Companies
3.4 Global Prokinetic Drug Sales by Companies
3.5 Global Prokinetic Drug Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Prokinetic Drug Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Prokinetic Drug Product Type
3.8 Tier 1, Tier 2 and Tier 3 Prokinetic Drug Players in Global Market
3.8.1 List of Global Tier 1 Prokinetic Drug Companies
3.8.2 List of Global Tier 2 and Tier 3 Prokinetic Drug Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Prokinetic Drug Market Size Markets, 2022 & 2029
4.1.2 Metoclopramide
4.1.3 Domperidone
4.1.4 Cisapride
4.1.5 Others
4.2 By Type – Global Prokinetic Drug Revenue & Forecasts
4.2.1 By Type – Global Prokinetic Drug Revenue, 2018-2023
4.2.2 By Type – Global Prokinetic Drug Revenue, 2024-2029
4.2.3 By Type – Global Prokinetic Drug Revenue Market Share, 2018-2029
4.3 By Type – Global Prokinetic Drug Sales & Forecasts
4.3.1 By Type – Global Prokinetic Drug Sales, 2018-2023
4.3.2 By Type – Global Prokinetic Drug Sales, 2024-2029
4.3.3 By Type – Global Prokinetic Drug Sales Market Share, 2018-2029
4.4 By Type – Global Prokinetic Drug Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Prokinetic Drug Market Size, 2022 & 2029
5.1.2 Gastroparesis
5.1.3 Constipation
5.1.4 Reflux Esophagitis
5.1.5 Functional Dyspepsia
5.2 By Application – Global Prokinetic Drug Revenue & Forecasts
5.2.1 By Application – Global Prokinetic Drug Revenue, 2018-2023
5.2.2 By Application – Global Prokinetic Drug Revenue, 2024-2029
5.2.3 By Application – Global Prokinetic Drug Revenue Market Share, 2018-2029
5.3 By Application – Global Prokinetic Drug Sales & Forecasts
5.3.1 By Application – Global Prokinetic Drug Sales, 2018-2023
5.3.2 By Application – Global Prokinetic Drug Sales, 2024-2029
5.3.3 By Application – Global Prokinetic Drug Sales Market Share, 2018-2029
5.4 By Application – Global Prokinetic Drug Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Prokinetic Drug Market Size, 2022 & 2029
6.2 By Region – Global Prokinetic Drug Revenue & Forecasts
6.2.1 By Region – Global Prokinetic Drug Revenue, 2018-2023
6.2.2 By Region – Global Prokinetic Drug Revenue, 2024-2029
6.2.3 By Region – Global Prokinetic Drug Revenue Market Share, 2018-2029
6.3 By Region – Global Prokinetic Drug Sales & Forecasts
6.3.1 By Region – Global Prokinetic Drug Sales, 2018-2023
6.3.2 By Region – Global Prokinetic Drug Sales, 2024-2029
6.3.3 By Region – Global Prokinetic Drug Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Prokinetic Drug Revenue, 2018-2029
6.4.2 By Country – North America Prokinetic Drug Sales, 2018-2029
6.4.3 US Prokinetic Drug Market Size, 2018-2029
6.4.4 Canada Prokinetic Drug Market Size, 2018-2029
6.4.5 Mexico Prokinetic Drug Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Prokinetic Drug Revenue, 2018-2029
6.5.2 By Country – Europe Prokinetic Drug Sales, 2018-2029
6.5.3 Germany Prokinetic Drug Market Size, 2018-2029
6.5.4 France Prokinetic Drug Market Size, 2018-2029
6.5.5 U.K. Prokinetic Drug Market Size, 2018-2029
6.5.6 Italy Prokinetic Drug Market Size, 2018-2029
6.5.7 Russia Prokinetic Drug Market Size, 2018-2029
6.5.8 Nordic Countries Prokinetic Drug Market Size, 2018-2029
6.5.9 Benelux Prokinetic Drug Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Prokinetic Drug Revenue, 2018-2029
6.6.2 By Region – Asia Prokinetic Drug Sales, 2018-2029
6.6.3 China Prokinetic Drug Market Size, 2018-2029
6.6.4 Japan Prokinetic Drug Market Size, 2018-2029
6.6.5 South Korea Prokinetic Drug Market Size, 2018-2029
6.6.6 Southeast Asia Prokinetic Drug Market Size, 2018-2029
6.6.7 India Prokinetic Drug Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Prokinetic Drug Revenue, 2018-2029
6.7.2 By Country – South America Prokinetic Drug Sales, 2018-2029
6.7.3 Brazil Prokinetic Drug Market Size, 2018-2029
6.7.4 Argentina Prokinetic Drug Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Prokinetic Drug Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Prokinetic Drug Sales, 2018-2029
6.8.3 Turkey Prokinetic Drug Market Size, 2018-2029
6.8.4 Israel Prokinetic Drug Market Size, 2018-2029
6.8.5 Saudi Arabia Prokinetic Drug Market Size, 2018-2029
6.8.6 UAE Prokinetic Drug Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Sumitomo
7.1.1 Sumitomo Company Summary
7.1.2 Sumitomo Business Overview
7.1.3 Sumitomo Prokinetic Drug Major Product Offerings
7.1.4 Sumitomo Prokinetic Drug Sales and Revenue in Global (2018-2023)
7.1.5 Sumitomo Key News & Latest Developments
7.2 Johnson & Johnson
7.2.1 Johnson & Johnson Company Summary
7.2.2 Johnson & Johnson Business Overview
7.2.3 Johnson & Johnson Prokinetic Drug Major Product Offerings
7.2.4 Johnson & Johnson Prokinetic Drug Sales and Revenue in Global (2018-2023)
7.2.5 Johnson & Johnson Key News & Latest Developments
7.3 Sanofi
7.3.1 Sanofi Company Summary
7.3.2 Sanofi Business Overview
7.3.3 Sanofi Prokinetic Drug Major Product Offerings
7.3.4 Sanofi Prokinetic Drug Sales and Revenue in Global (2018-2023)
7.3.5 Sanofi Key News & Latest Developments
7.4 Kyowa Kirin Pharmaceuticals
7.4.1 Kyowa Kirin Pharmaceuticals Company Summary
7.4.2 Kyowa Kirin Pharmaceuticals Business Overview
7.4.3 Kyowa Kirin Pharmaceuticals Prokinetic Drug Major Product Offerings
7.4.4 Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales and Revenue in Global (2018-2023)
7.4.5 Kyowa Kirin Pharmaceuticals Key News & Latest Developments
7.5 Pfizer
7.5.1 Pfizer Company Summary
7.5.2 Pfizer Business Overview
7.5.3 Pfizer Prokinetic Drug Major Product Offerings
7.5.4 Pfizer Prokinetic Drug Sales and Revenue in Global (2018-2023)
7.5.5 Pfizer Key News & Latest Developments
7.6 Teva
7.6.1 Teva Company Summary
7.6.2 Teva Business Overview
7.6.3 Teva Prokinetic Drug Major Product Offerings
7.6.4 Teva Prokinetic Drug Sales and Revenue in Global (2018-2023)
7.6.5 Teva Key News & Latest Developments
7.7 Cadila Pharmaceuticals
7.7.1 Cadila Pharmaceuticals Company Summary
7.7.2 Cadila Pharmaceuticals Business Overview
7.7.3 Cadila Pharmaceuticals Prokinetic Drug Major Product Offerings
7.7.4 Cadila Pharmaceuticals Prokinetic Drug Sales and Revenue in Global (2018-2023)
7.7.5 Cadila Pharmaceuticals Key News & Latest Developments
7.8 Hanmi Pharm
7.8.1 Hanmi Pharm Company Summary
7.8.2 Hanmi Pharm Business Overview
7.8.3 Hanmi Pharm Prokinetic Drug Major Product Offerings
7.8.4 Hanmi Pharm Prokinetic Drug Sales and Revenue in Global (2018-2023)
7.8.5 Hanmi Pharm Key News & Latest Developments
8 Global Prokinetic Drug Production Capacity, Analysis
8.1 Global Prokinetic Drug Production Capacity, 2018-2029
8.2 Prokinetic Drug Production Capacity of Key Manufacturers in Global Market
8.3 Global Prokinetic Drug Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Prokinetic Drug Supply Chain Analysis
10.1 Prokinetic Drug Industry Value Chain
10.2 Prokinetic Drug Upstream Market
10.3 Prokinetic Drug Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Prokinetic Drug Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Prokinetic Drug in Global Market
Table 2. Top Prokinetic Drug Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Prokinetic Drug Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Prokinetic Drug Revenue Share by Companies, 2018-2023
Table 5. Global Prokinetic Drug Sales by Companies, (K Units), 2018-2023
Table 6. Global Prokinetic Drug Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Prokinetic Drug Price (2018-2023) & (US$/Unit)
Table 8. Global Manufacturers Prokinetic Drug Product Type
Table 9. List of Global Tier 1 Prokinetic Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Prokinetic Drug Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Prokinetic Drug Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Prokinetic Drug Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Prokinetic Drug Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Prokinetic Drug Sales (K Units), 2018-2023
Table 15. By Type - Global Prokinetic Drug Sales (K Units), 2024-2029
Table 16. By Application – Global Prokinetic Drug Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Prokinetic Drug Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Prokinetic Drug Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Prokinetic Drug Sales (K Units), 2018-2023
Table 20. By Application - Global Prokinetic Drug Sales (K Units), 2024-2029
Table 21. By Region – Global Prokinetic Drug Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Prokinetic Drug Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Prokinetic Drug Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Prokinetic Drug Sales (K Units), 2018-2023
Table 25. By Region - Global Prokinetic Drug Sales (K Units), 2024-2029
Table 26. By Country - North America Prokinetic Drug Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Prokinetic Drug Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Prokinetic Drug Sales, (K Units), 2018-2023
Table 29. By Country - North America Prokinetic Drug Sales, (K Units), 2024-2029
Table 30. By Country - Europe Prokinetic Drug Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Prokinetic Drug Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Prokinetic Drug Sales, (K Units), 2018-2023
Table 33. By Country - Europe Prokinetic Drug Sales, (K Units), 2024-2029
Table 34. By Region - Asia Prokinetic Drug Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Prokinetic Drug Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Prokinetic Drug Sales, (K Units), 2018-2023
Table 37. By Region - Asia Prokinetic Drug Sales, (K Units), 2024-2029
Table 38. By Country - South America Prokinetic Drug Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Prokinetic Drug Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Prokinetic Drug Sales, (K Units), 2018-2023
Table 41. By Country - South America Prokinetic Drug Sales, (K Units), 2024-2029
Table 42. By Country - Middle East & Africa Prokinetic Drug Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Prokinetic Drug Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Prokinetic Drug Sales, (K Units), 2018-2023
Table 45. By Country - Middle East & Africa Prokinetic Drug Sales, (K Units), 2024-2029
Table 46. Sumitomo Company Summary
Table 47. Sumitomo Prokinetic Drug Product Offerings
Table 48. Sumitomo Prokinetic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 49. Sumitomo Key News & Latest Developments
Table 50. Johnson & Johnson Company Summary
Table 51. Johnson & Johnson Prokinetic Drug Product Offerings
Table 52. Johnson & Johnson Prokinetic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 53. Johnson & Johnson Key News & Latest Developments
Table 54. Sanofi Company Summary
Table 55. Sanofi Prokinetic Drug Product Offerings
Table 56. Sanofi Prokinetic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 57. Sanofi Key News & Latest Developments
Table 58. Kyowa Kirin Pharmaceuticals Company Summary
Table 59. Kyowa Kirin Pharmaceuticals Prokinetic Drug Product Offerings
Table 60. Kyowa Kirin Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 61. Kyowa Kirin Pharmaceuticals Key News & Latest Developments
Table 62. Pfizer Company Summary
Table 63. Pfizer Prokinetic Drug Product Offerings
Table 64. Pfizer Prokinetic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 65. Pfizer Key News & Latest Developments
Table 66. Teva Company Summary
Table 67. Teva Prokinetic Drug Product Offerings
Table 68. Teva Prokinetic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 69. Teva Key News & Latest Developments
Table 70. Cadila Pharmaceuticals Company Summary
Table 71. Cadila Pharmaceuticals Prokinetic Drug Product Offerings
Table 72. Cadila Pharmaceuticals Prokinetic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 73. Cadila Pharmaceuticals Key News & Latest Developments
Table 74. Hanmi Pharm Company Summary
Table 75. Hanmi Pharm Prokinetic Drug Product Offerings
Table 76. Hanmi Pharm Prokinetic Drug Sales (K Units), Revenue (US$, Mn) and Average Price (US$/Unit) (2018-2023)
Table 77. Hanmi Pharm Key News & Latest Developments
Table 78. Prokinetic Drug Production Capacity (K Units) of Key Manufacturers in Global Market, 2021-2023 (K Units)
Table 79. Global Prokinetic Drug Capacity Market Share of Key Manufacturers, 2021-2023
Table 80. Global Prokinetic Drug Production by Region, 2018-2023 (K Units)
Table 81. Global Prokinetic Drug Production by Region, 2024-2029 (K Units)
Table 82. Prokinetic Drug Market Opportunities & Trends in Global Market
Table 83. Prokinetic Drug Market Drivers in Global Market
Table 84. Prokinetic Drug Market Restraints in Global Market
Table 85. Prokinetic Drug Raw Materials
Table 86. Prokinetic Drug Raw Materials Suppliers in Global Market
Table 87. Typical Prokinetic Drug Downstream
Table 88. Prokinetic Drug Downstream Clients in Global Market
Table 89. Prokinetic Drug Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Prokinetic Drug Segment by Type in 2022
Figure 2. Prokinetic Drug Segment by Application in 2022
Figure 3. Global Prokinetic Drug Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Prokinetic Drug Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Prokinetic Drug Revenue, 2018-2029 (US$, Mn)
Figure 7. Prokinetic Drug Sales in Global Market: 2018-2029 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by Prokinetic Drug Revenue in 2022
Figure 9. By Type - Global Prokinetic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Prokinetic Drug Revenue Market Share, 2018-2029
Figure 11. By Type - Global Prokinetic Drug Sales Market Share, 2018-2029
Figure 12. By Type - Global Prokinetic Drug Price (US$/Unit), 2018-2029
Figure 13. By Application - Global Prokinetic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Prokinetic Drug Revenue Market Share, 2018-2029
Figure 15. By Application - Global Prokinetic Drug Sales Market Share, 2018-2029
Figure 16. By Application - Global Prokinetic Drug Price (US$/Unit), 2018-2029
Figure 17. By Region - Global Prokinetic Drug Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Prokinetic Drug Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Prokinetic Drug Revenue Market Share, 2018-2029
Figure 20. By Region - Global Prokinetic Drug Sales Market Share, 2018-2029
Figure 21. By Country - North America Prokinetic Drug Revenue Market Share, 2018-2029
Figure 22. By Country - North America Prokinetic Drug Sales Market Share, 2018-2029
Figure 23. US Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Prokinetic Drug Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Prokinetic Drug Sales Market Share, 2018-2029
Figure 28. Germany Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 29. France Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Prokinetic Drug Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Prokinetic Drug Sales Market Share, 2018-2029
Figure 37. China Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 41. India Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Prokinetic Drug Revenue Market Share, 2018-2029
Figure 43. By Country - South America Prokinetic Drug Sales Market Share, 2018-2029
Figure 44. Brazil Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Prokinetic Drug Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Prokinetic Drug Sales Market Share, 2018-2029
Figure 48. Turkey Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Prokinetic Drug Revenue, (US$, Mn), 2018-2029
Figure 52. Global Prokinetic Drug Production Capacity (K Units), 2018-2029
Figure 53. The Percentage of Production Prokinetic Drug by Region, 2022 VS 2029
Figure 54. Prokinetic Drug Industry Value Chain
Figure 55. Marketing Channels


★調査レポート[世界の運動促進薬市場予測2023-2029：メトクロプラミド、ドンペリドン、シサプリド、その他] (コード：MMG23LY8609)販売に関する免責事項を必ずご確認ください。
★調査レポート[世界の運動促進薬市場予測2023-2029：メトクロプラミド、ドンペリドン、シサプリド、その他]についてメールでお問い合わせ
◆関連市場調査レポート◆
  • 世界の腰痛治療薬市場予測2023-2029：急性用治療薬、慢性用治療薬
  • 世界の長時間作用型統合失調症治療薬市場予測2023-2029：経口薬、注射剤
  • 世界の高シュウ酸尿症一次治療薬市場予測2023-2029：ALLN-230、DCR-PHXC、ALN-GO1、その他
  • 世界の筋肉内薬物送達装置市場予測2023-2029：分子構造、ポリマー、ゲル、その他
  • 世界の二重抗体薬市場予測2023-2029：レモバブ、BLINCYTO、その他

    • ◆H&Iグローバルリサーチのお客様（例）◆